Maetzold Derek J's Form 4 filing
Castle Biosciences Inc (CSTL) · filed Oct 21, 2021
- Accession no.
- 0001447362-21-000241
- Filed
- Oct 21, 2021
- Trade date
- Oct 19-20, 2021
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 15 non-derivative transactions. Open-market sales total $331.2K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Maetzold Derek JCIK 0001239501 | Director, Officer (Pres. & Chief Exec. Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Oct 19, 2021 | Common Stock | SSaleDisposed | −133 | $66.13F2 | −$8,795.29 | 131,328 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −300 | $67.07F4 | −$20,121 | 131,028 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −400 | $67.80F5 | −$27,120 | 130,628 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −133 | $66.13F2 | −$8,795.29 | 154,167 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −300 | $67.07F4 | −$20,121 | 153,867 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −400 | $67.80F5 | −$27,120 | 153,467 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −134 | $66.13F2 | −$8,861.42 | 141,565 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −300 | $67.07F4 | −$20,121 | 141,265 | Indirect | |
| Oct 19, 2021 | Common Stock | SSaleDisposed | −400 | $67.80F5 | −$27,120 | 140,865 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −700 | $65.04F8 | −$45,528 | 129,928 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −134 | $66.05F9 | −$8,850.7 | 129,794 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −700 | $65.04F8 | −$45,528 | 152,767 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −133 | $66.05F9 | −$8,784.65 | 152,634 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −700 | $65.04F8 | −$45,528 | 140,165 | Indirect | |
| Oct 20, 2021 | Common Stock | SSaleDisposed | −133 | $66.05F9 | −$8,784.65 | 140,032 | Indirect |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
This transaction was executed in multiple trades at prices ranging from $65.530 to $66.480, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F4
This transaction was executed in multiple trades at prices ranging from $66.580 to $67.510, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F5
This transaction was executed in multiple trades at prices ranging from $67.590 to $68.385, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F8
This transaction was executed in multiple trades at prices ranging from $64.650 to $65.530, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.
- F9
This transaction was executed in multiple trades at prices ranging from $65.650 to $66.580, inclusive. The price reported above reflects the weighted-average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.
Referenced by the price of 3 transactions in Table I.